Jupiter Neurosciences, Inc. (JUNS)
NASDAQ · Manufacturing · Pharmaceutical preparations
JUNS price, last 12 months
Key stats
- Previous close
- $2.89
- Open
- $2.90
- Day range
- $2.67 – $2.97
- 52-week range
- $2.67 – $137.96
- Volume
- 56.8K
- Avg volume (20 days)
- 79K
- Market cap
- $3.5M
Performance
Technicals and fundamentals
About Jupiter Neurosciences, Inc.
Jupiter Neurosciences Inc is a clinical-stage research and development company focused on developing treatments for neuroinflammation through the resveratrol platform. Its platform product, JOTROL, is an enhanced oral formulation of resveratrol, which has many potential indications. In the larger disease areas, which are targeting Parkinson's Disease. The group is presently in the process of conducting a Phase IIa clinical trial in Parkinson's Disease. The company operates through two reportable segments: premium nutritional supplements and pharmaceutical operations focused on drug candidates for CNS and rare orphan diseases. It generates the majority of its revenue from Premium Nutritional Supplements, which includes commercialization and sales of the Company's Nugevia product line.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $3.5M